NEW YORK, Oct 3 - Coulter Pharmaceutical (Nasdaq: CLTR) said Tuesday it had entered into a collaboration with Cobra Therapeutics, the gene therapy subsidiary of ML Laboratories, to jointly develop and commercialize Cobra's gene expression technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.